International Phenome Center Network
The IPCN is a consortium of leading universities and research centres, working together to advance global healthcare through metabolic phenotyping
02/05/2017
Congratulations to Australian National Phenome Centre on their opening!
Metabolomics@Murdoch on Twitter “The official announcement of the Australian National Phenome Centre at opening night!! ”
22/12/2016
Bruker Announces Corporate Partnership with International Phenome Centre Network (IPCN) for NMR Technologies and SOPs The International Phenome Centre Network (IPCN), founded by Imperial College London and more than a dozen international partners in Australia , Canada , China , Japan , Singapore , Taiwan , the US, and the UK ( www.phenomenetwork.org ), was launched officially this week at the 2016 World Innovation…
22/12/2016
Inauguration of the International Phenome Centre Network at Doha On November 29th, Imperial inaugurated the International Phenome Centre Network (IPCN), at the WISH conference in Doha. Building on the best-practices established at the MRC-NIHR National Phenome Centre, the IPCN will promote global harmonisation in the field of metabolic phenotyping, and using the…
12/12/2016
Inaugural members of the IPCN signing up at the 2016 World Innovation Summit for Health.
Today the IPCN launched at the WISH conference in Doha.
Dame Sally Davies, the UK's Chief Medical Officer stated:
“Phenomic research really is one of the next medical frontiers which can advance our understanding of a whole raft of diseases and conditions. The way we treat autism, cancers, mental health, stroke, obesity, metabolic diseases and type 2 diabetes could all be revolutionised by research in this area. It is also really good for work to cross international boundaries to find ways of tackling the biggest global public health challenges facing us today faster.”
For more information see our website at http://phenomenetwork.org